The Personal Glucose Meter (PGM) is a widely available and proven medical device that is used by millions of diabetics around the globe. Today’s glucose meter is the culmination of over 30 years of engineering and development efforts to make it do one thing extraordinarily well: measure blood glucose levels anytime, anywhere. GlucoSentient has developed a powerful technology that transforms the PGM into a device capable of quantitatively and conveniently detecting other non-glucose targets. Their technology translates the amount of non-glucose target to glucose. The amount of glucose is then measured by the PGM. GlucoSentient is currently focusing on the development of POC medical monitoring devices utilizing this innovative technology.
GlucoSentient was founded by Yi Lu. He is the Jay and Ann Schenck Professor in the Departments of Chemistry, Biochemistry, Materials Science and Engineering, and Bioengineering at the University of Illinois.
EnterpriseWorks Tenure: 2012-2018
News & Milestones
GlucoSentient Now
After graduating from EnterpriseWorks in 2018, GlucoSentient has expanded into a corporate office in Research Park.